Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

The Measurement of Nocturnal Hypokinesia in Parkinson's Disease (PD) Patient Compared With Spouse by Wearable Sensors

Trial N/A Unknown Feb. 1, 2015

A Study of MK0657 in Parkinson's Disease Patients (0657-006)

Trial Phase 1 Completed Jan. 28, 2015

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Trial Phase 2 Unknown Jan. 26, 2015

Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 Parkinsonism

Trial Phase 2 Completed Jan. 25, 2015

Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

Trial Phase 1 Completed Jan. 20, 2015

Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

Trial Phase 3 Completed Jan. 15, 2015

Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

Trial Phase 3 Completed Jan. 15, 2015

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Trial Phase 3 Completed Jan. 15, 2015

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Trial Phase 3 Completed Jan. 15, 2015

Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide

Trial Phase 1 Completed Jan. 14, 2015

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Trial Phase 1 Completed Jan. 14, 2015

Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

Trial Phase 1 Completed Jan. 13, 2015

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease

Trial Phase 1 Completed Jan. 11, 2015

A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Trial Phase 2 Completed Jan. 11, 2015

Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites

Trial Phase 1 Completed Jan. 8, 2015

A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

Trial Phase 1 Completed Jan. 7, 2015

Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

Trial Phase 1 Withdrawn Jan. 7, 2015

Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

Trial Phase 3 Completed Dec. 22, 2014

Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease

Trial Phase 2 Terminated Dec. 17, 2014

Effect of Opicapone at Steady State on Warfarin Pharmacokinetics

Trial Phase 1 Completed Dec. 1, 2014